Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

FDG-PET/CT in radiation treatment planning of head and neck squamous cell carcinoma.

Arens AI, Troost EG, Schinagl D, Kaanders JH, Oyen WJ.

Q J Nucl Med Mol Imaging. 2011 Oct;55(5):521-8. Review.

2.

¹⁸F-FDG-PET imaging in radiotherapy tumor volume delineation in treatment of head and neck cancer.

Delouya G, Igidbashian L, Houle A, Bélair M, Boucher L, Cohade C, Beaulieu S, Filion EJ, Coulombe G, Hinse M, Martel C, Després P, Nguyen-Tan PF.

Radiother Oncol. 2011 Dec;101(3):362-8. doi: 10.1016/j.radonc.2011.07.025.

PMID:
21885143
3.

Comparison between CT- and FDG-PET-defined target volumes for radiotherapy planning in head-and-neck cancers.

Henriques de Figueiredo B, Barret O, Demeaux H, Lagarde P, De-Mones-Del-Pujol E, Kantor G, de Clermont-Gallerande H, Richaud P, Fernandez P.

Radiother Oncol. 2009 Dec;93(3):479-82. doi: 10.1016/j.radonc.2009.09.010.

PMID:
19880207
4.

Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.

Anderson CM, Chang T, Graham MM, Marquardt MD, Button A, Smith BJ, Menda Y, Sun W, Pagedar NA, Buatti JM.

Int J Radiat Oncol Biol Phys. 2015 Mar 1;91(3):472-9. doi: 10.1016/j.ijrobp.2014.11.002.

5.

Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer.

Moeller BJ, Rana V, Cannon BA, Williams MD, Sturgis EM, Ginsberg LE, Macapinlac HA, Lee JJ, Ang KK, Chao KS, Chronowski GM, Frank SJ, Morrison WH, Rosenthal DI, Weber RS, Garden AS, Lippman SM, Schwartz DL.

J Clin Oncol. 2009 May 20;27(15):2509-15. doi: 10.1200/JCO.2008.19.3300.

6.

Is image registration of fluorodeoxyglucose-positron emission tomography/computed tomography for head-and-neck cancer treatment planning necessary?

Fried D, Lawrence M, Khandani AH, Rosenman J, Cullip T, Chera BS.

Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):748-54. doi: 10.1016/j.ijrobp.2011.12.071.

PMID:
22414285
7.

PET/CT significance for planning radiotherapy of head and neck cancer.

Kolarova I, Vanasek J, Kandrnal V, Odrazka K, Dusek L, Chrobok V, Belohlavek O, Dolezel M, Petruzelka L, Michalek R, Jarkovsky J.

Neoplasma. 2012;59(5):536-40. doi: 10.4149/neo_2012_069.

PMID:
22668019
8.

Recurrences after intensity modulated radiotherapy for head and neck squamous cell carcinoma more likely to originate from regions with high baseline [18F]-FDG uptake.

Due AK, Vogelius IR, Aznar MC, Bentzen SM, Berthelsen AK, Korreman SS, Loft A, Kristensen CA, Specht L.

Radiother Oncol. 2014 Jun;111(3):360-5. doi: 10.1016/j.radonc.2014.06.001.

9.

FDG-PET/CT-guided intensity modulated head and neck radiotherapy: a pilot investigation.

Schwartz DL, Ford EC, Rajendran J, Yueh B, Coltrera MD, Virgin J, Anzai Y, Haynor D, Lewellen B, Mattes D, Kinahan P, Meyer J, Phillips M, Leblanc M, Krohn K, Eary J, Laramore GE.

Head Neck. 2005 Jun;27(6):478-87.

PMID:
15772953
10.

Comparison of CT- and FDG-PET-defined GT: in regard to Paulino et al. (Int J Radiat Oncol Biol Phys 2005;61:1385-1392).

Gregoire V, Daisne JF, Geets X.

Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):308-9; author reply 309. No abstract available.

PMID:
16111601
11.

Hypoxia-guided adaptive radiation dose escalation in head and neck carcinoma: a planning study.

Servagi-Vernat S, Differding S, Sterpin E, Hanin FX, Labar D, Bol A, Lee JA, Grégoire V.

Acta Oncol. 2015 Jul;54(7):1008-16. doi: 10.3109/0284186X.2014.990109.

PMID:
25562382
12.

FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma.

Schwartz DL, Ford E, Rajendran J, Yueh B, Coltrera MD, Virgin J, Anzai Y, Haynor D, Lewellyn B, Mattes D, Meyer J, Phillips M, Leblanc M, Kinahan P, Krohn K, Eary J, Laramore GE.

Int J Radiat Oncol Biol Phys. 2005 Jan 1;61(1):129-36.

PMID:
15629603
13.

F-18 FDG PET-CT fusion in radiotherapy treatment planning for head and neck cancer.

Koshy M, Paulino AC, Howell R, Schuster D, Halkar R, Davis LW.

Head Neck. 2005 Jun;27(6):494-502.

PMID:
15772951
14.

Workflow and radiation safety implications of (18)F-FDG PET/CT scans for radiotherapy planning.

Sam S, Shon IH, Vinod SK, Lin P, Lin M.

J Nucl Med Technol. 2012 Sep;40(3):175-7. doi: 10.2967/jnmt.111.099440.

15.

Role of (18)F-FDG PET-CT in head and neck squamous cell carcinoma.

Castaldi P, Leccisotti L, Bussu F, Miccichè F, Rufini V.

Acta Otorhinolaryngol Ital. 2013 Feb;33(1):1-8. Review.

16.

Role of FDG-PET/CT in staging and follow-up of head and neck squamous cell carcinoma.

Mak D, Corry J, Lau E, Rischin D, Hicks RJ.

Q J Nucl Med Mol Imaging. 2011 Oct;55(5):487-99. Review.

17.

18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study.

Roh JL, Park JP, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY.

Radiology. 2014 Apr;271(1):153-61. doi: 10.1148/radiol.13131470.

PMID:
24475791
18.

Positron emission tomography for radiation treatment planning.

Grosu AL, Piert M, Weber WA, Jeremic B, Picchio M, Schratzenstaller U, Zimmermann FB, Schwaiger M, Molls M.

Strahlenther Onkol. 2005 Aug;181(8):483-99. Review.

PMID:
16044216
19.

FDG-PET/CT during concomitant chemo radiotherapy for esophageal cancer: Reducing target volumes to deliver higher radiotherapy doses.

Nkhali L, Thureau S, Edet-Sanson A, Doyeux K, Benyoucef A, Gardin I, Michel P, Vera P, Dubray B.

Acta Oncol. 2015 Jun;54(6):909-15. doi: 10.3109/0284186X.2014.973062.

PMID:
25417733
20.

Detailed characterization of the early response of head-neck cancer xenografts to irradiation using (18)F-FDG-PET imaging.

Huang J, Chunta JL, Amin M, Lee DY, Grills IS, Wong CY, Yan D, Marples B, Martinez AA, Wilson GD.

Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):485-91. doi: 10.1016/j.ijrobp.2011.11.053.

PMID:
22331000
Items per page

Supplemental Content

Support Center